Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Shereen A. Dasuqi"'
Autor:
Mohamad-Hani Temsah, Fadi Aljamaan, Shuliweeh Alenezi, Noura Abouammoh, Khalid Alhasan, Shereen A. Dasuqi, Ali Alhaboob, Mohammed A. Hamad, Rabih Halwani, Abdulkarim Alrabiaah, Sarah Alsubaie, Fatimah S. Alshahrani, Fahad AlZamil, Ziad A. Memish, Mazin Barry, Jaffar A. Al-Tawfiq
Publikováno v:
Vaccines, Vol 10, Iss 12, p 2071 (2022)
Background: Monkeypox disease (MPOX) recently re-emerged in May 2022, causing international outbreaks in multiple non-endemic countries. This study demonstrates a novel comparison between the knowledge and perceptions of Saudi healthcare workers (HCW
Externí odkaz:
https://doaj.org/article/11e12966f5304100a456a17741c127b5
Autor:
Mohammed A Hamad, Shereen A Dasuqi, Aamer Aleem, Rasha A Omran, Rakan M AlQahtani, Fahad A Alhammad, Abdulaziz H Alzeer
Publikováno v:
SAGE Open Medicine, Vol 9 (2021)
Introduction: Critically ill COVID-19 patients are at increased risk of thrombosis with an enhanced risk of bleeding. We aimed to explore the role of anti-factor Xa levels in optimizing the high-intensity anticoagulation’s safety and efficacy and f
Externí odkaz:
https://doaj.org/article/3da5cc53b9f3452187c2550ea2070c27
Publikováno v:
World Journal of Pharmacology. 12:12-17
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::40251b434e0674ddd5f05f91a8ea6bfb
https://doi.org/10.5497/wjp.v12.i2.12
https://doi.org/10.5497/wjp.v12.i2.12
Autor:
Abdullah AlAhmadi, Saeed Alqahtani, Fadi Aljamaan, Mohammed A. Hamad, Rasha A Omran, Saeed Ali Syed, Turki AlJaloud, Abdullah Alsultan, Shereen A Dasuqi
Publikováno v:
Saudi Pharmaceutical Journal : SPJ
Background Meropenem is commonly used in the ICU to treat gram-negative infections. Due to various pathophysiological changes, critically ill patients are at higher risk of having subtherapeutic concentrations and hence have a higher risk of treatmen
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::47f82c406ba5cb9f6b9b00c015cf2d16
http://europepmc.org/articles/PMC8596159
http://europepmc.org/articles/PMC8596159
Autor:
Fahad A Alhammad, Mohammed A Hamad, Aamer Aleem, Rakan M AlQahtani, Shereen A Dasuqi, Rasha A Omran, Abdulaziz H. Alzeer
Publikováno v:
SAGE Open Medicine
SAGE Open Medicine, Vol 9 (2021)
SAGE Open Medicine, Vol 9 (2021)
Introduction: Critically ill COVID-19 patients are at increased risk of thrombosis with an enhanced risk of bleeding. We aimed to explore the role of anti-factor Xa levels in optimizing the high-intensity anticoagulation’s safety and efficacy and f
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4d38e967e76b73ca9c389a3f6b4b86d7
http://europepmc.org/articles/PMC8516376
http://europepmc.org/articles/PMC8516376